In non-endemic countries, the access to healthcare for migrants and other patients with NTDs may be hampered by new barriers linked to the COVID-19 pandemic. Low awareness of health care professionals on the opportunistic potential of some NTDs may lead to unfavorable outcome of COVID-19 patients treated with immunomodulatory drugs.
All Keywords
【저자키워드】 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), migrants, Chagas disease, Immunosuppressive treatment, screening programs, Leishmaniasis, strongyloidiasis,
【저자키워드】 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), migrants, Chagas disease, Immunosuppressive treatment, screening programs, Leishmaniasis, strongyloidiasis,